ROLE OF ADIPOKINES IN THE PROGRESSION OF COLORECTAL CANCER


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Measurement of serum leptin levels in patients with colorectal cancer (CRC) may be used as an additional study to assess the prognosis of the disease irrespective of its stage. Patients with a special pretreatment serum leptin level of >30 ng should be included into a group at high risk for CRC progression.

Full Text

Restricted Access

About the authors

V. Chkhikvadze

Russian Roentgenoradiology Research Center

Moscow

U. Stanoyevich

Russian Roentgenoradiology Research Center

Moscow

E. Dekhissi

Russian Roentgenoradiology Research Center

Moscow

E. Kudinova

Russian Roentgenoradiology Research Center

Moscow

T. Kulinich

Russian Roentgenoradiology Research Center

Moscow

I. Stanoyevich

Endocrinology Research Center

Moscow

I. Trotsenko

Russian Roentgenoradiology Research Center

Moscow

References

  1. Агаджанян Н.А., Чижов А.Я., Ким Т.А. Болезни цивилизации // Экология человека. - 2003; 4: 9.
  2. Бутрова С.А. Висцеральное ожирение - ключевое звено метаболического синдрома. // Международный эндокринологический журнал. - 2009; 2: 20.
  3. Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган // Ожирение и метаболизм. - 2006; 1: 6-13.
  4. Дехисси Е.И., Станоевич У.С., Гребенкин Е.Н. и др. Патогенетические особенности колоректального рака на фоне нарушений жирового и углеводного обмена // Вестник Российского научного центра рентгенорадиологии Минздрава России. - 2013; 2 (13): 5.
  5. Метаболический синдром. Под ред. чл.-корр. РАМН Г.Е. Ройтберга / М.: МЕД-М-пресс-информ, 2007.
  6. Станоевич У.С., Дехисси Е.И., Чхиквадзе В.Д. Колоректальный рак при ожирении: патогенетические аспекты // Врач. - 2012; 8: 23-8.
  7. Amemori S., Ootani A., Aoki S. et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro // Am. J. Physiol. Gastrointest. Liver Physiol. - 2007; 292: 923-9.
  8. Anand P., Kunnumakkara A., Sundaram C. et al. Cancer is a preventable disease that requires major lifestyle changes // Pharm. Res. - 2008; 25: 2097116.
  9. Aparicio T., Kotelevets L., Tsocas A. et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice // Gut. - 2005; 54: 1136-45.
  10. Braun S., Bitton-Worms K., LeRoith D. The link between the metabolic syndrome and cancer // Int. J. Biol. Sci. - 2011; 7: 1003-101.
  11. Calle E., Rodriguez C., Walker-Thurmond K. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults // N. Engl. J. Med. - 2003; 348 (17): 1625-38.
  12. Calle E., Thun M. Obesity and cancer // Oncogene. - 2004; 23: 6365-78.
  13. Deng Y., Scherer P. Аdipokines as novel biomarkers and regulators of the metabolic syndrome // Ann. N. Y. Acad. Sci. - 2010; 1212: 1-1910.
  14. Donohoe C., Doyle S., Reynolds J. Visceral adiposity, insulin resistance and cancer risk // Diabetol. Metab. Syndr. - 2011; 3: 12.
  15. Finucane M., Stevens G., Cowan M. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants // Lancet. - 2011; 377: 557-671.
  16. Fruhbeck G., Jebb S., Prentice A. Leptin: physiology and pathophysiology // Clin. Physiology. - 1998; 18: 399-419.
  17. Galic S., Oakhill J. Adipose tissue as an endocrine organ // Steinberg GRMol Cell Endocrinol. - 2010; 316 (2): 129-39.
  18. Hardwick J., Van Den Brink G., Offerhaus G. et al. Leptin is a growth factor for colonic epithelial cells // Gastroenterology. - 2001; 121: 79-90.
  19. Hoda M., Keely S., Bertelsen L. et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells // Br. J. Surg. - 2007; 94: 346-54.
  20. Howe L., Subbaramaiah K., Hudis C. Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer // Clin. Cancer Res. -2013; 19: 6074-83.
  21. Neels J., Olefsky J. Inflamed fat: what starts the fire? // J. Clin. Invest. -2006; 116 (1): 33-5.
  22. Paik S., Jang S., Jang K. et al. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma // Ann. Surg. Oncol. - 2009; 16: 297-303.
  23. Pais R., Silaghi H., Silaghi A. et al. Metabolic syndrome and risk of subsequent colorectal cancer // World J. Gastroenterol. - 2009; 15: 5141-8.
  24. Park J., Euhus D., Scherer P. Paracrine and endocrine effects of adipose tissue on cancer development and progression // Endocr. Rev. - 2011; 32: 55070.
  25. Rouet-Benzineb P., Aparicio T., Guilmeau S. et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling // J. Biol. Chem. - 2004; 279: 16495-502.
  26. Scheid M., Sweeney G. The role of adiponectin signaling in metabolic syndrome and cancer // Rev. Endocr. Metab. Disord. - 2013; 10: 1-25.
  27. Shoelson S., Lee J., Yuan M. Inflammation and the IKK beta/I kappa B/ NF-kappa B axis in obesity- and diet-induced insulin resistance // Int. J. Obes. Relat. Metab. Disord. - 2003; 27 (3): 49-52.
  28. Van Kruijsdijk R., van der Wall E., Visseren F. Obesity and cancer: the role of dysfunctional adipose tissue // Cancer Epidemiol. Biomarkers Prev. - 2009; 18: 2569-78.
  29. Wajchenberg B., Giannella-Neto D., da Silva M. et al. Depotspecific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome // Horm. Metab. Res. - 2002; 34: 616-21.
  30. Wolk A., Gridley G., Svensson M. et al. A prospective study of obesity and cancer risk (Sweden) // Cancer Causes Control. - 2001; 12: 13-21.
  31. Wozniak S., Gee L., Wachtel M. Adipose tissue: the new endocrine organ? A review article // Dig. Dis. Sci. - 2009; 54: 1847-56.
  32. Xu H., Barnes G., Yang Q. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance // J. Clin. Invest. -2003; 112 (12): 1821-30.
  33. Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling // Int. J. Obes. Relat. Metab. Disord. - 2003; 27 (3): 56-60.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies